Fidelity International
CLDX icon

Fidelity International’s Celldex Therapeutics CLDX Stock Holding History

Fidelity International’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-6,967
Closed -$1.85M – 508
2014
Q1 		$1.85M Buy
+6,967
New +$2.67M 0.01% 528

Other funds holding CLDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity International's CLDX Position: Q2 2014 in Review

Fidelity International sold out of Celldex Therapeutics (CLDX) in Q2 2014, closing a stake of 6,967 shares — an estimated $1.85M sold.

Fidelity International first reported a position in CLDX in Q1 2014 and held it in 1 quarter. The position peaked at $1.85M in Q1 2014. 135 funds tracked by Wall St. Rank hold CLDX as of Q2 2014.

  • Fidelity International reported no remaining Celldex Therapeutics position as of Q2 2014 after selling out during the quarter.
  • Fidelity International sold 6,967 Celldex Therapeutics shares in Q2 2014, an estimated $1.85M.
  • Fidelity International first reported a position in Celldex Therapeutics in Q1 2014 and held it in 1 quarter.
  • Fidelity International's Celldex Therapeutics position peaked at $1.85M in Q1 2014.
  • 135 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q2 2014.

Based on Fidelity International's 13F filing for Q2 2014, filed 14 Aug 2014.